Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Wednesday, April 04, 2012
Pharmaceutical Field - Pfizer may split branded and generic drug businesses
At a meeting with Goldman Sachs analysts, CEO Ian Read (pictured) indicated that he was willing to consider further divestment of non-core assets. According to analyst Jami Rubin, “a potential full-scale breakup” of Pfizer is on the cards.